Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7726 AL 7740

Neuropsychological domains and fitness to drive in mild cognitive impairment or Alzheimer's disease

Quintas JL, Trindade IOA, Gameiro KSD, Pitta LSR, Camargos EF, Nóbrega OT.

Accid Anal Prev. 2023 Oct;191:107188. doi: 10.1016/j.aap.2023.107188. Epub 2023 Jul 7.

[The exposome in the context of preventive measures for Alzheimer's and Parkinson's diseases]

Schäffer E, Piel J.

Nervenarzt. 2023 Oct;94(10):892-903. doi: 10.1007/s00115-023-01538-9. Epub 2023 Aug 28.

White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study

Gan J, Shi Z, Liu S, Li X, Liu Y, Zhu H, Shen L, Zhang G, Lu H, Gang B, Chen Z, Ji Y.

Eur J Neurol. 2023 Dec;30(12):3711-3721. doi: 10.1111/ene.16002. Epub 2023 Aug 7.

Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review

Price S, Ruppar TM.

Appl Nurs Res. 2023 Dec;74:151745. doi: 10.1016/j.apnr.2023.151745. Epub 2023 Oct 28.

Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment

Wang M, Sajobi TT, Hogan DB, Ganesh A, Seitz DP, Chekouo T, Forkert ND, Borrie MJ, Camicioli R, Hsiung GR, Masellis M, Moorhouse P, Tartaglia MC, Ismail Z, Smith EE.

Alzheimers Dement. 2023 Oct;19(10):4542-4548. doi: 10.1002/alz.12987. Epub 2023 Mar 15.

Lewy Body Dementia: An Overview of Promising Therapeutics

Skylar-Scott IA, Sha SJ.

Curr Neurol Neurosci Rep. 2023 Oct;23(10):581-592. doi: 10.1007/s11910-023-01292-0. Epub 2023 Aug 12.

Paraoxonases at the Heart of Neurological Disorders

Khalaf FK, Connolly J, Khatib-Shahidi B, Albehadili A, Tassavvor I, Ranabothu M, Eid N, Dube P, Khouri SJ, Malhotra D, Haller ST, Kennedy DJ.

Int J Mol Sci. 2023 Apr 7;24(8):6881. doi: 10.3390/ijms24086881.

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease

Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I.

Alzheimers Res Ther. 2023 Jun 8;15(1):106. doi: 10.1186/s13195-023-01249-y.

Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin

Tchekalarova J, Tzoneva R.

Int J Mol Sci. 2023 Feb 3;24(3):3022. doi: 10.3390/ijms24033022.

Metaproteogenomic analysis of saliva samples from Parkinson's disease patients with cognitive impairment

Arıkan M, Demir TK, Yıldız Z, Nalbantoğlu ÖU, Korkmaz ND, Yılmaz NH, Şen A, Özcan M, Muth T, Hanoğlu L, Yıldırım S.

NPJ Biofilms Microbiomes. 2023 Nov 18;9(1):86. doi: 10.1038/s41522-023-00452-x.

Gait and/or balance disturbances associated with Alzheimer's dementia among older adults with amnestic mild cognitive impairment: A longitudinal observational study

Ahn S, Chung JW, Crouter SE, Lee JA, Lee CE, Anderson JG.

J Adv Nurs. 2023 Dec;79(12):4815-4827. doi: 10.1111/jan.15768. Epub 2023 Jun 29.

Suitability of Goal Attainment Scaling in Older Adult Populations with Neurodegenerative Disease Experiencing Cognitive Impairment: A Systematic Review and Meta-Analysis

Fegter O, Santos H, Rademaker AW, Roberts AC, Rogalski E.

Gerontology. 2023;69(8):1002-1013. doi: 10.1159/000529984. Epub 2023 Mar 24.

Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease

Sousa NMF, Brucki SMD.

Arq Neuropsiquiatr. 2023 Feb;81(2):155-163. doi: 10.1055/s-0042-1758448. Epub 2023 Mar 2.

Association between animal protein sources and risk of neurodegenerative diseases: a systematic review and dose-response meta-analysis

Talebi S, Asoudeh F, Naeini F, Sadeghi E, Travica N, Mohammadi H.

Nutr Rev. 2023 Aug 10;81(9):1131-1143. doi: 10.1093/nutrit/nuac114.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias